Novel glycomimetics: Anomeric and N-glycosyl sulfonamides

Current Organic Chemistry

Volumn 16, Issue 14, 2012, Pages 1670-1676

  Colinas, Pedro A ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

Anomeric sulfonamides; Carbohydrates; Enzyme inhibition; Glycomimetics; N glycosyl sulfonamides

Indexed keywords

EID: 84862749937     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527212800840892     Document Type: Article

References (52)

1. Ernst, B.; Magnani, J. L., From carbohydrate leads to glycomimetic drugs. Nat. Rev. Drug Disc., 2009, 8(8), 661-677.
2. This review will not discuss the Danishefskýs work. His group reported on the reaction of glycals with iodonium disym-collidine perchlorate and benzenesulfonamide to afford stereoselectively 2-β-iodo-1-α- sulfonamidohexoses. This class of glycosylsulfonamides were used for the preparation of oligosaccharides with the 2-aminohexosesubunit. Note.
3. Danishefsky, S. J.; Bilodeau, M. T., Glycals in organic synthesis: The evolution of comprehensive strategies for the assembly of oligosaccharides and glycoconjugates of biological consequence. Angewandte Chemie (International Edition in English) 1996, 35 (13/14), 1381-1419.
4. Also we will not consider the synthesis of glycosidic compounds in which the sulfonamide functionality is not directly linked to the carbohydrate moiety.
5. Winum, J. Y.; Poulsen, S. A.; Supuran, C. T., Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med. Res. Rev., 2009, 29 (3), 419-435
6. Jakab, Z.; Fekete, A.; Borbás, A.; Lipták, A.; Antus, S., Synthesis of new sulfonic acid-containing oligosaccharide mimetics of sialyl Lewis A. Tetrahedron, 2010, 66 (13), 2404-2414.
7. Lipták, A.; Balla, E.; Jánossy, L.; Sajtos, F.; Szilágyi, L., The first synthesis of secondary sugar sulfonic acids by nucleophilic displacement reactions. Tetrahedron Lett., 2004, 45 (4), 839-842.
8. Knapp, S.; Darout, E.; Amorelli, B., New glycomimetics: Anomeric sulfonates, sulfenamides, and sulfonamides. J. Org. Chem., 2006, 71 (4), 1380-1389.
9. Czifrák, K.; Somsák, L., Synthesis of anomeric sulfonamides and their behaviour under radical-mediated bromination conditions. Carbohydrate Res., 2009, 344 (3), 269-277.
10. Knapp, S.; Vocadlo, D.; Gao, Z.; Kirk, B.; Lou, J.; Withers, S. G., NAGthiazoline, an N-acetyl-β-hexosaminidase inhibitor that implicates acetamido participation. J. Am. Chem. Soc., 1996, 118 (28), 6804-6805.
11. Owen, D. J.; Davis, C. B.; Hartnell, R. D.; Madge, P. D.; Thomson, R. J.; Chong, A. K. J.; Coppel, R. L.; Von Itzstein, M., Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents. Bioorg. Med. Chem. Lett., 2007, 17 (8), 2274-2277.
12. Lopez, M.; Drillaud, N.; Bornaghi, L. F.; Poulsen, S. A., Synthesis of Sglycosyl primary sulfonamides. J. Org. Chem., 2009, 74 (7), 2811-2816.
13. Lopez, M.; Bornaghi, L. F.; Innocenti, A.; Vullo, D.; Charman, S. A.; Supuran, C. T.; Poulsen, S. A., Sulfonamide linked neoglycoconjugates-A new class of inhibitors for cancer-associated carbonic anhydrases. J. Med. Chem., 2010, 53 (7), 2913-2926.
14. Lopez, M.; Paul, B.; Hofmann, A.; Morizzi, J.; Wu, Q. K.; Charman, S. A.; Innocenti, A.; Vullo, D.; Supuran, C. T.; Poulsen, S. A., S-glycosyl primary sulfonamides - A new structural class for selective inhibition of cancerassociated carbonic anhydrases. J. Med. Chem., 2009, 52 (20), 6421-6432.
15. Neri, D.; Supuran, C. T., Interfering with pH regulation in tumours as a therapeutic strategy. Nat. Rev. Drug Disc., 2011, 10(10), 767-777.
16. Winum, J. Y.; Scozzafava, A.; Montero, J. L.; Supuran, C. T., Inhibition of carbonic anhydrase IX: A new strategy against cancer. Anti-Cancer Agents in Med. Chem., 2009, 9 (6), 693-702.
17. Supuran, C. T., Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Disc.,2008, 7 (2), 168-181.
18. Pastoreková, S.; Barathova, M.; Kopacek, J.; Pastorek, J., Carbonic anhydrase inhibitors targeting cancer: Therapeutic, immunologic, and diagnostic tools targeting isoforms IX and XI. Drug Design of Zinc-enzyme Inhibitors; Supuran, C. T.; Winum, J.-Y., Ed.; Wiley: Hoboken 2009; pp. 193-222.
19. Lou, Y.; McDonald, P. C.; Oloumi, A.; Chia, S.; Ostlund, C.; Ahmadi, A.; Kyle, A.; Auf Dem Keller, U.; Leung, S.; Huntsman, D.; Clarke, B.; Sutherland, B. W.; Waterhouse, D.; Bally, M.; Roskelley, C.; Overall, C. M.; Minchinton, A.; Pacchiano, F.; Carta, F.; Scozzafava, A.; Touisni, N.; Winum, J. Y.; Supuran, C. T.; Dedhar, S., Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res., 2011, 71 (9), 3364-3376.
20. Kansy, M.; Senner, F.; Gubernator, K., Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem., 1998, 41 (7), 1007-1010.
21. Lopez, M.; Bornaghi, L. F.; Driguez, H.; Poulsen, S. A., Synthesis of sulfonamide- bridged glycomimetics. J. Org. Chem., 2011, 76 (9), 2965-2975.
22. Colinas, P. A.; Bravo, R. D., A Novel Sulfonamidoglycosylation of Glycals. Org. Lett., 2003, 5 (23), 4509-4511.
23. Owens, J. M.; Yeung, B. K. S.; Hill, D. C.; Petillo, P. A., Facile C1 epimerization of β-1-sulfonamidyl-2-deoxy-2-iodoglycopyranosides. J. Org. Chem., 2001, 66 (4), 1484-1486.
24. Batchelor, R. J.; Green, D. F.; Johnston, B. D.; Patrick, B. O.; Pinto, B. M., Conformational preferences in glycosylamines. Implications for the exoanomeric effect. Carbohydrate Res., 2001, 330 (3), 421-426.
25. Bravo, F.; Kassou, M.; Díaz, Y.; Castillón, S., Synthesis of erythro and threo furanoid glycals from 1- and 2-phenylselenenyl-carbohydrate derivatives. Carbohydrate Res., 2001, 336 (2), 83-97.
26. Colinas, P. A.; Bravo, R. D., Sulfonamidoglycosylation of methyl ribofuranosides: A novel approach to furanosylsulfonamides. Tetrahedron Lett., 2005, 46 (10), 1687-1689.
27. Colinas, P. A.; Núñez, N. A.; Bravo, R. D., Sulfonamidoglycosylation of methyl glycosides employing perchloric acid supported on silica gel. J. Carbohydrate Chem., 2008, 27 (3), 141-147.
28. Dalpozzo, R.; Bartoli, G.; Sambri, L.; Melchiorre, P., Perchloric acid and its salts: Very powerful catalysts in organic chemistry. Chemical Rev., 2010, 110 (6), 3501-3551.
29. Butera, A. P.; De Souza Filho, J. D.; Carvalho, D. T.; Figueiredo, R. C.; De Faria, L. C. A.; Nunes, M. A.; Prado, M. A. F.; Alves, R. J.; De Andrade, M. H. G.; Silva, K. T. S., Synthesis of amides and sulfonamides of β-Dgalactopyranosylamine and β -lactosylamine and evaluation of their interactions with the lectins from Erythrina cristagalli and Ricinus communis. Quim. Nova, 2007, 30 (5), 1267-1274.
30. Talan, R. S.; Sanki, A. K.; Sucheck, S. J., Facile synthesis of N-glycosyl amides using a N-glycosyl-2,4-dinitrobenzenesulfonamide and thioacids. Carbohydrate Res.,2009, 344 (15), 2048-2050.
31. Monsigny, M.; Quétard, C.; Bourgerie, S.; Delay, D.; Pichon, C.; Midoux, P.; Mayer, R.; Roche, A. C., Glycotargeting: The preparation of glyco-amino acids and derivatives from unprotected reducing sugars. Biochimie, 1998, 80 (2), 99-108.
32. Colinas, P. A.; Témpera, C. A.; Rodriguez, O. M.; Bravo, R. D., Stereoselective synthesis of novel N-β-glycosyl sulfonamides by sulfonamidoglycosylation of per-O-acetylated sugars. Synthesis, 2009, (24), 4143-4148.
33. Rodríguez, O. M.; Maresca, A.; Témpera, C. A.; Bravo, R. D.; Colinas, P. A.; Supuran, C. T., N-β-Glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII. Bioorg. Med. Chem., Lett., 2011, 21 (15), 4447-4450.
34. Ferrier, R. J.; Zubkov, O. A. Org. Reactions, 2003, 62, 569-736.
35. Chandrasekhar, S.; Reddy, C. R.; Chandrashekar, G., Tris(pentafluorophenyl)borane catalyzed Ferrier azaglycosylation with sulfonamides and carbamates. Tetrahedron Lett., 2004, 45 (34), 6481-6484.
36. Colinas, P. A.; Bravo, R. D., Ferrier sulfonamidoglycosylation of D-glycals. Carbohydrate Res.,2007, 342 (15), 2297-2302.
37. Colinas, P. A.; Bravo, R. D.; Echeverría, G. A., X-ray crystallographic and high-resolution NMR spectroscopy characterization of 4,6-di-O-acetyl-2,3- dideoxy- β-d-erythro-hex-2-enopyranosyl sulfamide. Carbohydrate Res., 2008, 343 (17), 3005-3008.
38. Alegre, M.L.; Diez, R. P.; Colinas, P. A., Experimental and theoretical study of the conformational, vibrational and magnetic properties of 4,6-di-Oacetyl- 2,3-dideoxy-D-threo-hex-2-enopyranosyl ethanesulfonamide. J. Mol. Struct., 2009, 919 (1/3), 223-226.
39. Lavecchia, M. J.; Diez, R. P.; Colinas, P. A., A combined theoretical and spectroscopic study of 4,6-di-O-acetyl-2,3-dideoxy-d-erythro-hex-2- enopyranosyl sulfamide: A novel glycosyl carbonic anhydrase IX inhibitor. Carbohydrate Res., 2011, 346 (3), 442-448.
40. Témpera, C. A.; Colinas, P. A.; Bravo, R. D., Efficient synthesis of 2,3- unsaturated sulfonamidoglycosides by Amberlyst 15. Tetrahedron Lett., 2010, 51 (41), 5372-5374.
41. De Angelis, A.; Ingallina, P.; Perego, C., Solid Acid Catalysts for Industrial Condensations of Ketones and Aldehydes with Aromatics. Indust. Eng. Chem. Res., 2004, 43 (5), 1169-1178.
42. Tian, Q.; Zhu, X. M.; Yang, J. S., Amberlyst 15-catalyzed efficient synthesis of 2,3-unsaturated glycosides via Ferrier rearrangement for glycal. Synthetic Comm., 2007, 37 (5), 691-701.
43. Ding, F.; William, R.; Gorityala, B. K.; Ma, J.; Wang, S.; Liu, X. W., A mild and efficient synthetic protocol for Ferrier azaglycosylation promoted by ZnCl2/Al2O3. Tetrahedron Lett., 2010, 51 (23), 3146-3148.
44. Colinas, P. A.; Bravo, R. D.; Vullo, D.; Scozzafava, A.; Supuran, C. T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties. Bioorg. Med. Chem. Lett., 2007, 17 (18), 5086-5090.
45. McDonald, P. C.; Winum, J.-Y.; Supuran, C. T.; Dedhar, S. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 2012, 3(1), 84-97.
46. Jordan, M. A.; Wilson, L., Microtubules as a target for anticancer drugs. Nat. Rev. Cancer, 2004, 4 (4), 253-265.
47. Shan, B.; Medina, J. C.; Santha, E.; Frankmoelle, W. P.; Chou, T. C.; Learned, R. M.; Narbut, M. R.; Stott, D.; Wu, P.; Jaen, J. C.; Rosen, T.; Timmermans, P. B. M. W. M.; Beckmann, H., Selective, covalent modification of β-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proceedings of the Nat. Acad. Sci. USA, 1999, 96 (10), 5686-5691.
48. Baek, J. Y.; Hur, W.; Wang, J. S.; Bae, S. H.; Yoon, S. K., Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. World J. Gastroenterol., 2007, 13 (8), 1175-1181.
49. Tong, Z.; Wu, X.; Chen, C. S.; Kehrer, J. P., Cytotoxicity of a noncyclooxygenase- 2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells. Lung Cancer, 2006, 52 (1), 117-124.
50. Chen, J.; Liu, T.; Dong, X.; Hu, Y., Recent development and SAR analysis of colchicine binding site inhibitors. Mini-Reviews in Medicinal Chemistry 2009, 9 (10), 1174-1190.
51. Crespo, R.; De Bravo, M. G.; Colinas, P. A.; Bravo, R. D., In vitro antitumor activity of N-glycosyl sulfonamides. Bioorg. Med. Chem. Lett., 2010, 20 (22), 6469-6471.
52. Marques, S. M.; Enyedy, E. A.; Supuran, C. T.; Krupenko, N. I.; Krupenko, S. A.; Amélia Santos, M., Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity. Bioorg. Med. Chem., 2010, 18 (14), 5081-5089.